Aidoc

Overview
News
Clinical Decision Support Systems?
Product stageSegments
Early
?
Diagnostic support
?

Aidoc is a pioneering provider of artificial intelligence (AI) solutions for healthcare. Founded in 2016 by CEO Elad Walach, CTO Michael Braginsky, and VP of R&D and CISO Guy Reiner, the company develops AI algorithms that analyze medical imaging data, electronic health records, and other clinical sources. Aidoc's AI Care Platform operates as an intelligent layer on top of hospital IT systems, offering physicians actionable insights to streamline clinical workflows across the continuum of care.

The company's flagship product, the AI Care Platform, comprises FDA-cleared clinical solutions for various pathologies, including intracranial hemorrhage, pulmonary embolism, and large-vessel occlusion. These AI algorithms work behind the scenes, analyzing imaging studies and alerting radiologists to potential critical cases, enabling faster diagnosis and treatment.

Aidoc's technology has demonstrated its potential to expedite patient diagnosis, reduce time to treatment, shorten emergency department length of stay, and improve clinical outcomes. The company has partnered with over 1,000 hospitals and health centers globally, including leading medical institutions in the US, Europe, and Israel. In November 2023, Aidoc announced a USD 30 million investment to create the first-of-its-kind AI foundation model for medical imaging, aiming to further enhance diagnostic accuracy and accelerate algorithm development.

In June 2022, Aidoc raised USD 110 million in a Series D funding round, bringing its total investment to USD 250 million. The company has achieved significant growth, with over 250 employees in Israel and 100 worldwide as of June 2022, and aims to continue expanding its workforce.

Key customers and partnerships

Aidoc has formed strategic partnerships with prominent healthcare organizations, including Radiology Partners, a leading radiology practice in the US. The company's AI solutions are utilized by top medical centers such as Cedars-Sinai Medical Center in Los Angeles and Assuta Medical Centers, Israel's largest private medical network.

Assuta has integrated Aidoc's AI tools to detect intracranial hemorrhages and pulmonary embolisms, enabling imaging technicians to promptly identify critical cases and expedite patient care. Additionally, Assuta collaborates with Aidoc through its innovation arm, RISE, to foster AI development and deployment in radiology, pathology, and genomics.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
Aminadav 3, Tel Aviv Tel Aviv ISR
Founded year:
2016
Employees:
251-500
IPO status:
Private
Total funding:
USD 264.0 mn
Last Funding:
USD 30.0 mn (Series Unknown; Nov 2023)
Last valuation:
-
Key competitors
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.